Anti-hepatitic C virus antibodies hidden in circulating antibody/antigen aggregates in HCV-RNA positive patients

Microbios

Volumn 103, Issue 404, 2000, Pages 59-64

  Quiros Roldan E ^a   Piedrola G ^a   Maroto, M C ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

HCV antigen antibody aggregates; HCV RNA; Hepatitis C virus

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HUMAN; IMMUNOLOGY; MALE; METHODOLOGY; MIDDLE AGED;

ADULT; ANTIGEN-ANTIBODY COMPLEX; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED;

EID: 0034567760     PISSN: 00262633     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. AIYAMA T., Yoshioka K., Okumura A., Takayma M., Iwata K., Ishikawa T. and Kakumu S. 1996. Sequence analysis of hypervariable region of HCV associated with immune complex in patients with chronic HCV infection. J. infect. Dis. 174 1316-20.
2. BASSET S. E., Brasky K. M. and Lanford R. E. 1998. Analysis of HCV-inoculated chimpanzees reveals unexpected clinical profiles. J. Virol. 72 2589-99.
3. CABEZAS T., Quirós E., García F., Hernández-Quero J., Bernal M. C., Martínez A., de la Higuera J., Piédrola G. and Maroto M. C. 1994. Immune complex p24 antigen: a new prognostic marker in human immunodeficiency virus infection. Infection 22 4-7.
4. DE MEDINA M., Hill M., Sullivan H. O., Leclerq B., Pennell J., Jeffers L., Reddy K., Schiff E. and Pérez G. 1998. Detection of anti-HCV antibodies in patients undergoing dialysis by utilizing a HCV 3.0 assay: correlation with HCV-RNA. J. Lab. clin. Med. 132 73-5.
5. DIENSTAG S. L., Bhan A. K., Alter J., Feinstone S. M. and Purcell R. 1979. Circulating immune complexes in non-A, non-B hepatitis: possible masking of viral antigen. Lancet i 1265-7.
6. DOBSON S. R., Taber L. and Baughn R. E. 1988. Characterization of components in the circulating IC from infants with congenital syphilis. J. infect. Dis. 158 940-7.
7. ENGEL P. M. and Dennin R. H. 1998. Supplementary anti-HCV testing with 2nd and 3rd generation recombinant immunoblot assay and matrix applied to enzyme immunoassay positive sera and comparison with HCV-RNA detection. Zentbl. Bakt. 288 267-75.
8. HIJIKATA M., Shimizu Y. K., Kato H., Iwamoto A., Shih J., Alter H., Purcell R. and Yoshikura H. 1993. Equilibrium centrifugation studies of HCV: evidence for circulating immune complexes. J. Virol. 67 1953-8.
9. JONES V. E. and Orlans E. 1981. Isolation of immune complexes and characterization of their constituent antigens and antibodies in some human diseases: a review. J. Immunol. Meth. 44 249-70.
10. LEE H. and Allin J. P. 1998. Genomic screening for blood-borne viruses in transfusion settings. Vox Sang. 74 (Suppl 2) 119-23.
11. LEFRERE J. J., Guiramand S., Lefrere F., Mariotti M., Aumont P., Lerble J., Petiti J., Girot R. and Morand L. 1997. Full or partial seroversion in patients infected by HCV. J. infect. Dis. 175 316-22.
12. LINTON E., Smilie D., Neal K. R., Irwing W., Underwood J. and James V. 1998. Association between MHC class II alleles and clearance of circulating HCV. J. infect. Dis. 178 39-44.
13. MURPHY A. L., Bush M. P., Cornett P. and Vyas G. N. 1998. A prospective study of the risk of transfusion-acquired viral infections. Tranfus. Med. 8 173-8.
14. PAWLOTSKY J. M. 1998. HCV infection: virus/host interactions. J. viral. Hepat. 5(Suppl 1) 3-8.
15. PAWLOTSKY J. M., Lonjon I., Hezode C., Raynard B., Darthuy F., Ramire J., Soussy C. and Dhumeaux D. 1998. What strategy should be used for diagnosis of HCV infection in clinical laboratories? Hepatol. 27 1700-2.
16. REESINK H. W., Engelfriet C. P., Vrielink H., Krusius T., Lankinen M., Flanagan P., Barbara J., Gill P., Dodd R., Bush M. P., Prati D., Mozzi F., Sirchia G., Diekam P., Epstein J., Tabor E., Martin-Vega C. and Hernández J. M. 1998. Consequences of nucleic acid amplification testing for blood transfusion centres. Vox Sang. 74 263-70.
17. SCHOTTSTEDT V., Tuma W., Bunger G. and Lefevre H. 1998. PCR for HBV, HCV and HIV-1 experiences and first results from a routine screening programme in a large blood transfusion service. Biologicals 26 101-4.
18. TROISI C. L. and Hollinger F. 1997. Detection of antibodies to HCV in seronegative patients using an immune complex dissociation assay. J. viral. Hepat. 4 383-6.
19. VAN DER BURG P. J., Vrielink H. and Reesink H. W. 1998. Donor selection: the exclusion of high risk donors? Vox Sang. 74(Suppl 2) 499-502.
20. VRIELINK H. and Reesink H. W. 1998. Transfusion-transmissible infections. Curr. Opin. Hematol. 5 396-405.
21. ZEIN N. N., Germer J. J., Wendt N. K., Schimek C. M., Thorvilson J. N., Mitchell P. S. and Persing D. H. 1997. Indeterminate results of the second-generation HCV recombinant immunoblot assay: significance of high-level c22-3 reactivity and influence of HCV genotypes. J. clin. Microbiol. 35 311-2.